Iwate Medical University Hospital
Morioka 112-0015
2 studies enrolling now · 12 studies all time
What they study most
Arrhythmias, Cardiac, Carcinoma, Non-Small-Cell Lung, Colitis, Ulcerative, Crohn Disease, Crohn's Disease, Non-small Cell Lung Cancer, Ulcerative Colitis, Ulcerative Colitis Chronic
Studies at this site
- A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis — Recruiting now
- Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer — Recruiting now
- A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
- A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
- Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis — Running, not enrolling
- Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease — Stopped early
- Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease — Completed
- Reveal LINQ Registry — Completed
- Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis — Completed
- A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer — Stopped early